ACCENDRA HEALTH INC
ACHNYSETrading Snapshot
- Day Range
- $0.20 β $0.23
- 52-Week Range
- $0.19 β $5.38
- Volume (shares)
- 1,255,363
- Avg Volume (shares)
- β
- Shares Outstanding
- 76.9M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $2.76B
- Last Q Revenue
- $613M
- P/E Ratio
- -0.1
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-3.94
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β0.6%
ACCENDRA HEALTH INC
ACHAbout ACCENDRA HEALTH INC
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the βNoticeβ) from the New York Stock Exchange (the βNYSEβ) notifying the Com

New Strong Sell Stocks for October 9th
ACH, ARDX and DPRO have been added to the Zacks Rank #5 (Strong Sell) List on October 9th, 2026.

New Strong Sell Stocks for October 6th
VLVLY, ACH and CCJ have been added to the Zacks Rank #5 (Strong Sell) List on October 6th, 2026.

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of Growth
Accendra Health, Inc. (NYSE: ACH) (the Γ’ΒΒCompanyΓ’ΒΒ) today named Kenneth Gardner-Smith as the Company's next President and Chief Executive Officer. Gardner-Smi

BlackRock Inc. Acquires New Stake in Accendra Health, Inc. $ACH
BlackRock Inc. acquired a new stake in Accendra Health, Inc. (NYSE: ACH) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 5,504,102

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the βCompanyβ) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions,